Mannkind (MNKD) Receivables - Other (2010 - 2023)

Mannkind (MNKD) posted quarterly Receivables - Other of $400000.0 for Q3 2023, down 33.33% year-over-year from $600000.0 in Q3 2022, and up 100.0% quarter-over-quarter from $200000.0 in Q2 2023.

Mannkind (MNKD) Receivables - Other (2010 - 2023) Analysis & Trends

Mannkind (MNKD) has reported Receivables - Other for 8 consecutive years, with $400000.0 the latest figure, recorded in Q3 2023.

  • In Q3 2023, Receivables - Other fell 33.33% year-over-year to $400000.0; the TTM figure through Sep 2023 stood at $400000.0 (down 33.33% YoY), while the FY2021 annual figure was $300000.0, changed N/A from the prior year.
  • Receivables - Other climbed to $400000.0 in Q3 2023 per MNKD's latest filing, from $200000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $700000.0 in Q1 2023 and bottomed at $200000.0 in Q2 2023.
  • Historically, Receivables - Other has averaged $442857.1 across 3 years, with a median of $400000.0 in 2022.
  • On a YoY basis, Receivables - Other climbed as much as 40.0% in 2023 and fell as far as 50.0% in 2023.
  • Mannkind's Receivables - Other stood at $300000.0 in 2021, then surged by 100.0% to $600000.0 in 2022, then plunged by 33.33% to $400000.0 in 2023.
  • Business Quant data shows MNKD's Receivables - Other at $400000.0 in Q3 2023, $200000.0 in Q2 2023, and $700000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Mannkind 1.19 Bn 1.08 Bn 94.97 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 400,000.00
Sep 30, 2023 400,000.00
Jun 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 700,000.00
Mar 31, 2023 700,000.00
Sep 30, 2022 600,000.00
Sep 30, 2022 600,000.00
Jun 30, 2022 400,000.00
Jun 30, 2022 400,000.00
Mar 31, 2022 500,000.00
Mar 31, 2022 500,000.00
Dec 31, 2021 300,000.00
Dec 31, 2021 300,000.00
Sep 30, 2014 803,000.00
Sep 30, 2014 803,000.00
Sep 30, 2013 298,000.00
Sep 30, 2013 298,000.00
Jun 30, 2013 450,000.00
Jun 30, 2013 450,000.00